Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephen Colagiuri

Showing results (161-170 of 176) with videos related to

Pageof 18
Sort By:
Circulation. Cardiovascular Quality and Outcomes|January 15, 2015
Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trialDavid Peiris, Tim Usherwood, Kathryn Panaretto, et al.
Diabetes Research and Clinical Practice|April 16, 2014
Strategies for implementing the WHO diagnostic criteria and classification of hyperglycaemia first detected in pregnancyStephen Colagiuri, Maicon Falavigna, Mukesh M Agarwal, et al.
Diabetes Research and Clinical Practice|April 22, 2021
Race/ethnicity and challenges for optimal insulin therapyNayla Cristina do Vale Moreira, Antonio Ceriello, Abdul Basit, et al.
The Lancet. Gastroenterology & Hepatology|July 15, 2021
Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseasesMohammed Eslam, Aijaz Ahmed, Jean-Pierre Després, et al.
Diabetes Research and Clinical Practice|August 3, 2021
REPRINT OF: CLASSIFICATION OF DIABETES MELLITUSAmanda Adler, Peter Bennett, Stephen Colagiuri Chair, et al.
Nature|November 23, 2007
Grand challenges in chronic non-communicable diseasesAbdallah S Daar, Peter A Singer, Deepa Leah Persad, et al.
Plos One|April 14, 2020
Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline dataRafael Gabriel, Nisa Boukichou Abdelkader, Tania Acosta, et al.
Diabetologia|December 12, 2025
Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk. Reply to Choi W [Letter]Najmeh Davoodian, Mojtaba Lotfaliany, Rachel R Huxley, et al.
Diabetologia|October 17, 2025
Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetesNajmeh Davoodian, Mojtaba Lotfaliany, Rachel R Huxley, et al.
The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.
Pageof 18

Showing results (161-170 of 176) with videos related to

Sort By:
Pageof 18
Circulation. Cardiovascular Quality and Outcomes|January 15, 2015
Effect of a computer-guided, quality improvement program for cardiovascular disease risk management in primary health care: the treatment of cardiovascular risk using electronic decision support cluster-randomized trialDavid Peiris, Tim Usherwood, Kathryn Panaretto, et al.
Diabetes Research and Clinical Practice|April 16, 2014
Strategies for implementing the WHO diagnostic criteria and classification of hyperglycaemia first detected in pregnancyStephen Colagiuri, Maicon Falavigna, Mukesh M Agarwal, et al.
Diabetes Research and Clinical Practice|April 22, 2021
Race/ethnicity and challenges for optimal insulin therapyNayla Cristina do Vale Moreira, Antonio Ceriello, Abdul Basit, et al.
The Lancet. Gastroenterology & Hepatology|July 15, 2021
Incorporating fatty liver disease in multidisciplinary care and novel clinical trial designs for patients with metabolic diseasesMohammed Eslam, Aijaz Ahmed, Jean-Pierre Després, et al.
Diabetes Research and Clinical Practice|August 3, 2021
REPRINT OF: CLASSIFICATION OF DIABETES MELLITUSAmanda Adler, Peter Bennett, Stephen Colagiuri Chair, et al.
Nature|November 23, 2007
Grand challenges in chronic non-communicable diseasesAbdallah S Daar, Peter A Singer, Deepa Leah Persad, et al.
Plos One|April 14, 2020
Early prevention of diabetes microvascular complications in people with hyperglycaemia in Europe. ePREDICE randomized trial. Study protocol, recruitment and selected baseline dataRafael Gabriel, Nisa Boukichou Abdelkader, Tania Acosta, et al.
Diabetologia|December 12, 2025
Impact of normoglycaemia and prediabetes definitions on the estimated benefits of regression from prediabetes to normoglycaemia for type 2 diabetes risk. Reply to Choi W [Letter]Najmeh Davoodian, Mojtaba Lotfaliany, Rachel R Huxley, et al.
Diabetologia|October 17, 2025
Regression from prediabetes to normoglycaemia and the role of cardiometabolic risk factors on the subsequent risk of developing type 2 diabetesNajmeh Davoodian, Mojtaba Lotfaliany, Rachel R Huxley, et al.
The New England Journal of Medicine|September 20, 2014
Follow-up of blood-pressure lowering and glucose control in type 2 diabetesSophia Zoungas, John Chalmers, Bruce Neal, et al.
Pageof 18